Review: taking Sucralfate and Omeprazole together


Summary

Drug interactions are reported among people who take Sucralfate and Omeprazole together. This review analyzes the effectiveness and drug interactions between Sucralfate and Omeprazole. It is created by eHealthMe based on reports of 2,167 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Sucralfate and Omeprazole >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Sucralfate

Sucralfate has active ingredients of sucralfate. It is often used in gastritis. (latest outcomes from Sucralfate 5,036 users)

Omeprazole

Omeprazole has active ingredients of omeprazole. It is often used in gastrooesophageal reflux disease. (latest outcomes from Omeprazole 112,454 users)

On Aug, 26, 2016

2,167 people who take Sucralfate, Omeprazole are studied.


Number of reports submitted per year:

Sucralfate and Omeprazole drug interactions.

Drug effectiveness over time:

Sucralfate:
  • < 1 month: 16.0% - (2 of 12 people)
  • 1 - 6 months: 22.0% - (2 of 9 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 50.0% - (1 of 2 people)
Omeprazole:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 20.0% - (1 of 5 people)
  • 5 - 10 years: 50.0% - (3 of 6 people)
  • 10+ years: 25.0% - (1 of 4 people)
  • not specified: 33.0% - (1 of 3 people)

Drug effectiveness by gender:

Sucralfate:
  • female: 28.0% - (6 of 21 people)
  • male: 37.0% - (6 of 16 people)
Omeprazole:
  • female: 45.0% - (11 of 24 people)
  • male: 22.0% - (4 of 18 people)

Drug effectiveness by age:

Sucralfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 33.0% - (3 of 9 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 45.0% - (5 of 11 people)
Omeprazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 60.0% - (3 of 5 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 40.0% - (4 of 10 people)
  • 50-59: 37.0% - (3 of 8 people)
  • 60+: 25.0% - (3 of 12 people)

Most common drug interactions over time *:

< 1 month:
  • pneumonia
  • dyspnoea
  • cytolytic hepatitis
  • diarrhoea
  • gastrointestinal haemorrhage
  • haemoglobin decreased
  • atrial fibrillation
  • drug eruption
  • escherichia infection
  • liver disorder
1 - 6 months:
  • atrial fibrillation
  • cholelithiasis
  • deep vein thrombosis
  • dyspnoea
  • oedema peripheral
  • abdominal sepsis
  • escherichia infection
  • gastrointestinal haemorrhage
  • pain
  • anorexia
6 - 12 months:
  • lupus nephritis
  • systemic lupus erythematosus
  • infection
  • depression
  • headache
  • nausea
  • abdominal pain
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • burning eyes
  • chest pain
1 - 2 years:
  • abdominal pain
  • nausea
  • anaemia
  • chest pain
  • cholelithiasis
  • constipation
  • deep vein thrombosis
  • dyspnoea
  • hypotension
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
2 - 5 years:
  • startle reflex
  • alopecia
  • chest pain
  • depression
  • epistaxis
  • gastrointestinal haemorrhage
  • neck pain
  • osteoporosis
  • pain
  • abdominal pain
5 - 10 years:
  • diarrhea
  • fall
  • iron deficiency anaemia
  • subdural haematoma
  • cardiac discomfort
  • gastrooesophageal reflux disease
  • pain
10+ years:
  • fall
  • osteoporosis
  • arthritis
  • road traffic accident
  • depression
  • osteoarthritis
  • ankle fracture
  • bone disorder
  • foot fracture
  • multiple fractures
not specified:
  • nausea
  • pain
  • depression
  • gastrooesophageal reflux disease
  • anxiety
  • fatigue
  • dyspnoea
  • diarrhoea
  • asthenia
  • anaemia

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • dyspnoea
  • depression
  • diarrhoea
  • gastrooesophageal reflux disease
  • fatigue
  • anxiety
  • fall
  • abdominal pain upper
male:
  • nausea
  • pyrexia
  • pain
  • anxiety
  • anaemia
  • hypotension
  • asthenia
  • thrombocytopenia
  • constipation
  • vomiting

Most common drug interactions by age *:

0-1:
  • drug ineffective
  • heart rate increased
2-9:
  • status epilepticus
  • cardiac failure congestive
  • drug ineffective
  • erythema nodosum
  • hypotension
  • ventricular hypertrophy
  • vomiting
  • drug maladministration
  • electrocardiogram qt prolonged
  • face oedema
10-19:
  • abdominal pain upper
  • pain
  • thrombocytopenia
  • cholecystitis chronic
  • drug ineffective
  • nausea
  • vomiting
  • infection
  • lupus nephritis
  • pneumonia
20-29:
  • nausea
  • abdominal pain
  • cholecystitis chronic
  • vomiting
  • abdominal pain upper
  • pain
  • cholelithiasis
  • pyrexia
  • weight decreased
  • hypokalaemia
30-39:
  • abdominal pain
  • nausea
  • fatigue
  • blood cholesterol increased
  • bronchitis
  • depression
  • pain
  • blood alkaline phosphatase increased
  • abdominal pain upper
  • arthralgia
40-49:
  • nausea
  • depression
  • chest pain
  • dyspnoea
  • anxiety
  • vomiting
  • bone disorder
  • pain
  • osteoarthritis
  • diarrhoea
50-59:
  • nausea
  • oedema peripheral
  • gastrooesophageal reflux disease
  • anxiety
  • dysphagia
  • depression
  • pain
  • cellulitis
  • diarrhoea
  • fatigue
60+:
  • pain
  • fall
  • dyspnoea
  • nausea
  • asthenia
  • anaemia
  • gastrooesophageal reflux disease
  • diarrhoea
  • drug ineffective
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Sucralfate and Omeprazole?

Can you answer these questions?

More questions for: Sucralfate, Omeprazole

You may be interested in these reviews

More reviews for: Sucralfate, Omeprazole

On eHealthMe, Sucralfate (sucralfate) is often used to treat gastritis. Omeprazole (omeprazole) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.